Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Avita Medical Ltd (RCEL)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Avita Medical's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
12.90 -0.58    -4.30%
03/12 - Closed. Currency in USD ( Disclaimer )
After Hours
12.90
0.00
0.00%
16:41:11 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US05380C1027 
CUSIP:  05380C102
  • Volume: 87,213
  • Bid/Ask: 11.00 / 14.22
  • Day's Range: 12.85 - 13.60
Avita Medical 12.90 -0.58 -4.30%
IndustryBiotechnology
SectorHealthcare
Employees

108

Equity Type

ADR

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company’s patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient’s own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.

Contact Information

Top Executives

Name Age Since Title
Fiona Melanie Wood - 2006 Founder and Member of Clinical Advisory Board
Suzanne Crowe 71 2016 Independent Non-Executive Director
Louis C. Drapeau 77 2016 Independent Non-Executive Director
Jeremy L. Curnock-Cook 71 2012 Independent Non-Executive Director
Louis James Panaccio 64 2014 Independent Non-Executive Chairman
Michael S. Perry 62 2017 CEO, President & Executive Director
James M. Corbett 63 2021 Independent Director
Jan Stern Reed 61 2021 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RCEL Comments

Write your thoughts about Avita Medical Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Plan Man
Plan Man Jun 13, 2021 10:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA approved for under 18s now. This will be $40 before long.
Duane Goodson
Duane Goodson Jan 04, 2021 11:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDGL 0.125 By 1/16/2021 FDA will provide a final decision to grant or deny their request for breakthrough designation.
Jeff Bernardi
Jeff Bernardi May 15, 2019 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this stock will soon be $15.
Frederick Bowen
Frederick Bowen May 15, 2019 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why are saying this??.
Jeff Bernardi
Jeff Bernardi May 15, 2019 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a great product and they will most likely be bought by a large company for huge money.
Anthony Jones
Anthony Jones May 15, 2019 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When will this buyout happen, after most invester have lost there faith ?
Dragan Soldat
Dragan Soldat May 15, 2019 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good call
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email